Pediatric PET/MR Image Registry



Status:Recruiting
Conditions:Cancer, Skin and Soft Tissue Infections, Lymphoma
Therapuetic Areas:Dermatology / Plastic Surgery, Oncology
Healthy:No
Age Range:Any - 40
Updated:4/17/2018
Start Date:February 1, 2018
End Date:March 1, 2020
Contact:Anne Muehe
Email:amuehe@stanford.edu
Phone:650-720-8601

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole
body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed
Tomography (CT) imaging for the diagnosis of tumors in children and young adults.
Sensitivities, specificities and diagnostic accuracies of the different imaging modalities
will be compared for significant differences.


Inclusion Criteria:

- Patients with proven solid tumors or newly diagnosed mass strongly suspected to
represent a solid tumor.

- We might also include some patients with leukemia if there is concern for a focal
lesion in any of their organs.

- Participant's parents (if participant is under 18) or the participant (if participant
is 18 years or older) must willingly give written informed consent prior to any image
transfer to the image registry.

Exclusion Criteria:

- Patient has contraindications for MRI or PET/MR. This includes patients with cardiac
pacemakers or intracranial vascular clips as well as patients with a blood glucose
level > 200 mg/dl.

- Lack of parental permission (if participant is younger than 18) or lack of informed
consent (if participant is at least 18 years of age).

- Patient has a CNS primary tumor.

- Pregnant women and fetuses
We found this trial at
1
site
Stanford University School of Medicine
Palo Alto, California 94304
Principal Investigator: Heike Daldrup-Link, MD
Phone: 650-720-8601
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials